Mitochondrial myopathy

3 trials 2 recruiting MedDRA PT
3 Registered trials
2 Recruiting
3 Unique sponsors
3 Unique IMPs
1 Commercial trials
Drug classes (ATC)
— ATC code not specified 3
Mechanism of action (INN-stem analysis)
Unknown / small molecule 3 substances
Phase III: 1 Phase II: 1 Phase I (First in Human): 1

Filter these 3 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 3 trials

Phase III

1 trial
  • Khondrion B.V. Commercial
    SONLICROMANOL
    2025-522361-30-00 5 countries 2026 n=160 Orphan
    Recruiting

Phase II

1 trial
  • Hospital Universitario 12 De Octubre Academic
    DOXRIBTIMINE, DOXECITINE
    2024-510763-35-00 1 country 2024 n=15
    Recruiting

Phase I (First in Human)

1 trial
  • Academisch Ziekenhuis Maastricht Academic
    AUTOLOGOUS MUSCLE PRECURSOR CELLS
    2024-515129-27-00 1 country n=20
    Pending
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Khondrion B.V. Commercial 1 Phase III 1
Hospital Universitario 12 De Octubre Academic 1 Phase II 1
Academisch Ziekenhuis Maastricht Academic 1 Phase I (First in Human) 0
New trials by year
2024
1
2026
1
← All indication landscapes